Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation

Neuropathology

Volumn 32, Issue 4, 2012, Pages 440-446

  Yoshida, Tomokatsu ^a   Nakagawa, Masanori ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Alexander disease; Astrocyte; Glial fibrillary acidic protein; Guideline; Rosenthal fiber

Indexed keywords

ALPHA CRYSTALLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN 27;

ALEXANDER DISEASE; ARTICLE; ASTROCYTE; DNA POLYMORPHISM; GENE; GENE CONTROL; GENE MUTATION; GFAP GENE; HUMAN; HYPERREFLEXIA; MACROCEPHALY; MUSCLE WEAKNESS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; SEIZURE;

ALEXANDER DISEASE; ANIMALS; ASTROCYTES; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MUTATION;

EID: 84864128089     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01268.x     Document Type: Article

References (39)

1. Alexander WS. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 1949; 72: 373-381.
2. Rosenthal W. Über eine eigenthϋmliche, mit Sylingomyelie complicirte Geschwulst des Ruckenmarks. Beitr Pathol Anat 1898; 23: 111-143.
3. Johnson AB, Bettica A. On-grid immunogold labeling of glial intermediate filaments in epoxy-embedded tissue. Am J Anat 1989; 185: 335-341.
4. Tomokane N, Iwaki T, Tateishi J etal. Rosenthal fibers share epitopes with αB-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold. Am J Pathol 1991; 138: 875-885.
5. Iwaki T, Kume-Iwaki A, Liem RK, Goldman JE. Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 1989; 57: 71-78.
6. Iwaki T, Iwaki A, Tateishi J etal. Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol 1993; 143: 487-495.
7. Brenner M, Johnson AB, Boespflug-Tanguy O etal. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 2001; 27: 117-120.
8. Farina L, Pareyson D, Minati L etal. Can MR imaging diagnose adult-onset Alexander disease? AJNR Am J Neuroradiol 2008; 29: 1190-1196.
9. Pareyson D, Fancellu R, Mariotti C etal. Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain 2008; 131: 2321-2331.
10. Balbi P, Salvini S, Fundarò C etal. The clinical spectrum of late-onset Alexander disease: a systematic literature review. J Neurol 2010; 257: 1955-1962.
11. Yoshida T, Sasayama H, Mizuta I etal. Glial fibrillary acidic protein mutations in adult-onset Alexander disease: clinical features observed in 12 Japanese cases. Acta Neurol Scand 2011; 124: 104-108.
12. Probst EN, Hagel C, Weisz V etal. Atypical focal MRI lesions in a case of juvenile Alexander's disease. Ann Neurol 2003; 53: 118-120.
13. van der Knaap MS, Salomons GS, Li R etal. Unusual variants of Alexander's disease. Ann Neurol 2005; 57: 327-338.
14. Niinikoski H, Haataja L, Brander A, Valanne L, Blaser S. Alexander disease as a cause of nocturnal vomiting in a 7-year-old girl. Pediatr Radiol 2009; 39: 872-875.
15. van der Knaap MS, Naidu S, Breiter SN etal. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001; 22: 541-552.
16. Yoshida T, Sasaki M, Yoshida M etal. Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. J Neurol 2011; 258: 1998-2008.
17. Shiihara T, Yoneda T, Mizuta I, Yoshida T, Nakagawa M, Shimizu N. Serial MRI changes in a patient Alexander disease and prolonged survival. Brain Dev 2011; 33: 604-607.
18. Romano S, Salvetti M, Ceccherini I, De Simone T, Savoiardo M. Brainstem signs with progressing atrophy of medulla oblongata and upper cervical cord. Lancet Neurol 2007; 6: 562-570.
19. Meins M, Brockmann K, Yadav S etal. Infantile Alexander disease: a GFAP mutation in monozygotic twins and novel mutations in two other patients. Neuropediatrics 2003; 33: 194-198.
20. Li R, Johnson AB, Salomons G etal. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol 2005; 57: 310-326.
21. Kinoshita T, Imaizumi T, Miura Y etal. A case of adult-onset Alexander disease with Arg416Trp human glial fibrillary acidic protein gene mutation. Neurosci Lett 2003; 350: 169-172.
22. Fuchs E. The cytoskeleton and disease: genetic disorders of intermediate filaments. Ann Rev Genet 1996; 30: 197-231.
23. Yoshida T, Tomozawa Y, Arisato T etal. The functional alteration of mutant GFAP depends on the location of the domain: morphological and functional studies using astrocytoma-derived cells. J Hum Genet 2007; 52: 362-369.
24. Hsiao VC, Tian R, Long H etal. Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP. J Cell Sci 2005; 118: 2057-2065.
25. Der Perng M, Su M, Wen SF etal. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of αB-crystallin and HSP27. Am J Hum Genet 2006; 79: 197-213.
26. Yoshida T, Sasayama H, Nakagawa M. The process of inducing GFAP aggregates in astrocytoma-derived cells is different between R239C and R416W mutant GFAP. A time-lapse recording study. Neurosci Lett 2009; 458: 11-14.
27. Tang G, Xu Z, Goldman JE. Synergistic effects of the SAPK/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease. J Biol Chem 2006; 281: 38634-38643.
28. Tang G, Yue Z, Talloczy Z etal. Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Hum Mol Genet 2008; 17: 1540-1555.
29. Tang G, Perng MD, Wilk S etal. Oligomers of mutant glial fibrillary acidic protein (GFAP) inhibit the proteasome system in Alexander disease astrocytes, and the small heat shock protein αB-crystallin reverses the inhibition. J Biol Chem 2010; 285: 10527-10537.
30. Meisingset TW, Risa Ø, Brenner M, Messing A. Alteration of glial-neuronal metabolic interactions in a mouse model of Alexander disease. Glia 2010; 58: 1228-1234.
31. Messing A, Head MW, Galles K. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am J Pathol 1998; 152: 391-398.
32. Cho W, Hagemann TL, Johnson DA etal. Dual transgenic reporter mice as a tool for monitoring expression of glial fibrillary protein. J Neurochem 2009; 110: 343-351.
33. Bachetti T, Di Zanni E, Lantieri F etal. A novel polymorphic AP-1 binding element of the GFAP promoter is associated with different allelic transcriptional activities. Ann Hum Genet 2010; 74: 506-515.
34. Hagemann TL, Gaeta SA, Smith MA etal. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. Hum Mol Genet 2005; 14: 2443-2458.
35. Hagemann TL, Connor JX, Messing A. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. J Neurosci 2006; 26: 11162-11173.
36. Tanaka KF, Takebayashi H, Yamazaki Y etal. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance. Glia 2007; 55: 617-631.
37. Cho W, Messing A. Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice. Exp Cell Res 2009; 315: 1260-1272.
38. Hagemann TL, Boelens WC, Wawrousek EF, Messing A. Suppression of GFAP toxicity by αB-crystallin in mouse models of Alexander disease. Hum Mol Genet 2009; 18: 1190-1199.
39. Wang L, Colodner KJ, Feany MB. Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease model. J Neurosci 2011; 31: 2868-2877.